vimarsana.com

Latest Breaking News On - Davidw boyer - Page 2 : vimarsana.com

Intrust Bank NA Has $392,000 Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Intrust Bank NA lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 18.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,977 shares of the company’s stock after selling 686 shares during the quarter. Intrust Bank […]

United-states
Neurocrine-biosciences
Davidw-boyer
Ingrid-delaet
Fifth-third-bancorp
Citigroup
Sunbelt-securities-inc
Neurocrine-biosciences-company-profile
Intrust-bank
Third-bancorp
Neurocrine-biosciences-inc
Nasdaq

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Intrust Bank NA

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Intrust Bank NA
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Tokio
Tokyo
Japan
United-states
Mizuho
Hokkaido
Alabama
Davidw-boyer
Neurocrine-biosciences
Ingrid-delaet
Linden-thomas-advisory-services
Needham-company

Certuity LLC Makes New $415,000 Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Certuity LLC purchased a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,150 shares of the company’s stock, valued at approximately $415,000. A number of other hedge funds also recently modified their […]

United-states
Eric-benevich
Davidw-boyer
Neurocrine-biosciences
Capital-partners
Citigroup
Securities-exchange-commission
Cantor-fitzgerald
Charles-schwab-investment-management-inc
Neurocrine-biosciences-inc
Barclays
Westfield-capital-management-co

Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Reaffirmed by Needham & Company LLC

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a report released on Tuesday, Benzinga reports. Other equities research analysts have also issued research reports about the company. Wells Fargo & Company upped their target price on Neurocrine Biosciences from $127.00 to […]

United-states
Los-angeles
California
Davidw-boyer
Neurocrine-biosciences
Ingrid-delaet
Wells-fargo-company
Securities-exchange-commission
Needham-company
Vanguard-group-inc
Brown-advisory-inc
Capital-partners

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Lifted by Larson Financial Group LLC

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Lifted by Larson Financial Group LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Ingrid-delaet
Neurocrine-biosciences
Zurcher-kantonalbank-zurich-cantonalbank
Davidw-boyer
Citigroup
Barclays
Larson-financial-group
Holdings-channel
Roman-butler-fullerton-co
Neurocrine-biosciences-inc
Nasdaq
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.